Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Transient Receptor Potential Vanilloid Type 1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion

Version 1 : Received: 8 December 2021 / Approved: 9 December 2021 / Online: 9 December 2021 (15:38:27 CET)

A peer-reviewed article of this Preprint also exists.

Castrejón-Téllez, V.; del Valle-Mondragón, L.; Pérez-Torres, I.; Guarner-Lans, V.; Pastelín-Hernández, G.; Ruiz-Ramírez, A.; Díaz-Juárez, J.A.; Varela-López, E.; Oidor-Chan, V.H.; Vargas-González, A.; Martínez-Memije, R.; Flores-Chávez, P.; León-Ruíz, B.; Arriaga-Carrillo, S.; Torres-Narváez, J.C. TRPV1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion. Molecules 2022, 27, 1031. Castrejón-Téllez, V.; del Valle-Mondragón, L.; Pérez-Torres, I.; Guarner-Lans, V.; Pastelín-Hernández, G.; Ruiz-Ramírez, A.; Díaz-Juárez, J.A.; Varela-López, E.; Oidor-Chan, V.H.; Vargas-González, A.; Martínez-Memije, R.; Flores-Chávez, P.; León-Ruíz, B.; Arriaga-Carrillo, S.; Torres-Narváez, J.C. TRPV1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion. Molecules 2022, 27, 1031.

Abstract

The transient vanilloid receptor potential type 1 (TRPV1) regulates neuronal and vascular functions mediated by nitric oxide (NO) and by the calcitonin gene-related peptide (CGRP). Here we study the participation of TRPV1 in the regulation of myocardial injury caused by ischemia-reperfusion and in the regulation of NO, tetrahydrobiopterin (BH4), the cGMP pathway, CGRP, total antioxidant capacity (TAC), malondialdehyde (MDA) and phosphodiesterase-3 (PDE-3). Isolated hearts of Wistar rats were used (according to Langendorff) to study the effects of capsaicin (CS), capsazepine (CZ) and CZ+CS treatments. The hearts were divided into three subgroups; 1) perfusion, 2) ischemia and 3) ischemia-reperfusion. In all groups we studied cardiac work and levels of NO, cGMP, BH4, CGRP, TAC, MDA and PDE-3 in ventricular tissue. Western blots were used to determine the expressions of eNOS, iNOS and phosphorylated NOS (pNOS). Structural changes were determined by histological evaluation. CS prevented damage caused by ischemia-reperfusion by improving cardiac work and the levels of NO, cGMP, BH4, TAC and CGRP. TRPV1 and iNOS expression were increased under ischemic conditions, while eNOS and pNOS were not modified. We conclude that the activation of TRPV1 constitutes a therapeutic possibility to counteract the damage caused by ischemia and reperfusion by regulating the NO pathway through CGRP.

Keywords

Ischemia reperfusion; TRPV1; cardioprotection

Subject

Medicine and Pharmacology, Pharmacology and Toxicology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.